# Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy

> **NCT05233540** · — · UNKNOWN · sponsor: **Aarhus University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Anal Cancer
- Locally Advanced Squamous Cell Carcinoma
- Oligometastatic Disease
- Circulating Tumor Cell
- Human Papilloma Virus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05233540
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05233540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05233540, "Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05233540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*